Pharmacological ablation of TRPV1+ fibers result in significantly alleviated psoriasis-like lesions accompanied by decreased expression of IL-23, IL-17, and IL-22 and decreased recruitment of inflammatory cells in the murine model of psoriasiform skin inflammation (99). The gene discussed is IL17A; the disease is psoriasis.